XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
 12 Months Ended
Jan. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The income tax expense (benefit) for fiscal years ended January 31, 2024 and 2023 is reconciled to the statutory federal income tax rates of 21% for the tax years ended January 31, is as follows (in thousands):
20242023
Statutory$6,140 $1,689 
State taxes (net of federal tax)1,346 746 
Change in valuation allowance(613)(10,546)
State rate adjustment164 6 
Change in unrecognized tax benefits34 35 
Stock compensation16 (397)
Expirations of attributes56 17 
Permanent differences69 (13)
Return to provision true-up118 (41)
Income tax expense (benefit)$7,330 $(8,504)

Significant components of the expense (benefit) for income taxes attributed to continuing operations are as follows for the years ended January 31, is as follows (in thousands):
 20242023
Current
Federal$5,567 $82 
State963 125 
6,530 207 
Deferred
Federal301 1,524 
State1,112 311 
1,413 1,835 
Change in valuation allowance(613)(10,546)
800 (8,711)
Income tax expense (benefit)$7,330 $(8,504)
Deferred tax assets and liabilities are comprised of the following as of January 31, respectively, as follows (in thousands):
 20242023
Deferred tax assets
Accrued vacation and sick leave$2,143 $1,925 
Retirement plans2,391 2,729 
Insurance reserves197 325 
Warranty128 156 
Net operating loss carryforwards599 1,949 
Right of use liability1,935 3,087 
   Inventory1,878 1,820 
Other536 401 
9,807 12,392 
Deferred tax liabilities
Tax in excess of book depreciation(882)(987)
Right of use assets(1,663)(2,630)
Other(377)(111)
(2,922)(3,728)
Valuation allowance(251)(864)
Net long term deferred tax asset$6,634 $7,800 

In assessing the realizability of deferred tax assets, the Company considers whether it is more-likely-than-not that some portion or all of its deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income or reversal of deferred tax liabilities during the periods in which those temporary differences become deductible. As a part of this evaluation, the Company assesses all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, the availability of tax carry backs, tax-planning strategies, and results of recent operations (including cumulative income (losses) in recent years), to determine whether sufficient future taxable income will be generated to realize existing deferred tax assets.

At January 31, 2024, the Company recorded a partial valuation allowances of $251,000 on certain state NOL to reduce the carrying amount of deferred tax assets to an amount that is more-likely-than-not to be realized. The net change in the valuation allowance for the year ended January 31, 2024, was a decrease of $613,000. At January 31, 2024, the Company had no NOL for U.S. federal tax purposes and $9.0 million for state income tax purposes, expiring at various dates through January 31, 2042. During the fiscal year ended January 31, 2023, the Company was profitable and returned to a cumulative 3-year profit in the fourth quarter. The Company benefited from continued growth in order rates, growth in sales volume, and improvements in gross margin. The Company utilized a material portion of its federal and certain state net operating loss carryforwards (“NOL”) in fiscal 2023 and anticipates that all federal NOL may be utilized by the end of fiscal 2024. During the fourth quarter of the year ended January 31, 2023, based on this evaluation, and after considering future reversals of existing taxable temporary differences and the effects of seasonality on the Company’s business, the Company determined the realization of a majority of the net deferred tax assets met the more-likely-than-not criteria and reversed a majority of its valuation allowances against its net deferred tax assets. At January 31, 2023, the Company recorded a partial valuation allowances of $864,000 on certain state NOL to reduce the carrying amount of deferred tax assets to an amount that is more-likely-than-not to be realized. The net change in the valuation allowance for the year ended January 31, 2023, was a decrease of $10.5 million. At January 31, 2023, the Company has NOL of approximately $2.7 million for U.S. federal tax purposes, with no expirations, and $25.1 million for state income tax purposes, expiring at various dates through January 31, 2041.

The following table summarizes the activity related to our gross unrecognized tax benefits for the years ended January 31, respectively, as follows (in thousands):
 20242023
Beginning balances as of January 31,$62 $57 
Increases related to prior year tax positions8 — 
Decreases related to prior year tax positions— (5)
Increases related to current year tax positions33 19 
Decreases related to lapsing of statute of limitations(11)(9)
Ending balance as of January 31,$92 $62 

At January 31, 2024, the Company’s unrecognized tax benefits associated with uncertain tax positions were $92,000, of which $73,000 if recognized, would favorably affect the effective tax rate.

The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense which is consistent with the recognition of the items in prior reporting. The Company had recorded a liability for interest and penalties related to unrecognized tax benefits of $37,000 at January 31, 2024, and $16,000 at January 31, 2023. The year ended January 31, 2018 and subsequent years remain open for examination by the IRS and state tax authorities. The Company is not currently under IRS or state examination.

The specific timing of when the resolution of each tax position will be reached is uncertain. As of January 31, 2024, it is reasonably possible that unrecognized tax benefits will decrease by $7,000 within the next 12 months due to the expiration of the statute of limitations.